The pharma major Cipla is the top gainer today on the Nifty index. The shares surged as much as 15 per cent to ₹589.65.
It had got the final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90 mcg from the USFDA, it said in a press release.
The drug is used in the treatment of acute events of bronchospasm.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.